These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25498856)

  • 1. Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies.
    Man KK; Tong HH; Wong LY; Chan EW; Simonoff E; Wong IC
    Neurosci Biobehav Rev; 2015 Feb; 49():82-9. PubMed ID: 25498856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.
    Brown HK; Hussain-Shamsy N; Lunsky Y; Dennis CE; Vigod SN
    J Clin Psychiatry; 2017 Jan; 78(1):e48-e58. PubMed ID: 28129495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review.
    Andalib S; Emamhadi MR; Yousefzadeh-Chabok S; Shakouri SK; Høilund-Carlsen PF; Vafaee MS; Michel TM
    Eur Psychiatry; 2017 Sep; 45():161-166. PubMed ID: 28917161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: A systematic review and meta-analysis.
    Kaplan YC; Keskin-Arslan E; Acar S; Sozmen K
    Reprod Toxicol; 2016 Dec; 66():31-43. PubMed ID: 27667009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.
    Leshem R; Bar-Oz B; Diav-Citrin O; Gbaly S; Soliman J; Renoux C; Matok I
    Curr Neuropharmacol; 2021; 19(6):896-906. PubMed ID: 33655866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder.
    Gidaya NB; Lee BK; Burstyn I; Yudell M; Mortensen EL; Newschaffer CJ
    J Autism Dev Disord; 2014 Oct; 44(10):2558-67. PubMed ID: 24803368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study.
    Yang F; Chen J; Miao MH; Yuan W; Li L; Liang H; Ehrenstein V; Li J
    BMJ Open; 2017 Dec; 7(12):e016368. PubMed ID: 29275337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis.
    Kobayashi T; Matsuyama T; Takeuchi M; Ito S
    Reprod Toxicol; 2016 Oct; 65():170-178. PubMed ID: 27474253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.
    Harrington RA; Lee LC; Crum RM; Zimmerman AW; Hertz-Picciotto I
    Autism Res; 2013 Jun; 6(3):149-68. PubMed ID: 23495208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
    Hviid A; Melbye M; Pasternak B
    N Engl J Med; 2013 Dec; 369(25):2406-15. PubMed ID: 24350950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant use during pregnancy and childhood autism spectrum disorders.
    Croen LA; Grether JK; Yoshida CK; Odouli R; Hendrick V
    Arch Gen Psychiatry; 2011 Nov; 68(11):1104-12. PubMed ID: 21727247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.
    Harrington RA; Lee LC; Crum RM; Zimmerman AW; Hertz-Picciotto I
    Pediatrics; 2014 May; 133(5):e1241-8. PubMed ID: 24733881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.
    Ames JL; Ladd-Acosta C; Fallin MD; Qian Y; Schieve LA; DiGuiseppi C; Lee LC; Kasten EP; Zhou G; Pinto-Martin J; Howerton EM; Eaton CL; Croen LA
    Biol Psychiatry; 2021 Aug; 90(4):253-262. PubMed ID: 34116791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.
    Boukhris T; Sheehy O; Mottron L; Bérard A
    JAMA Pediatr; 2016 Feb; 170(2):117-24. PubMed ID: 26660917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies.
    Kaplan YC; Keskin-Arslan E; Acar S; Sozmen K
    Br J Clin Pharmacol; 2017 Dec; 83(12):2798-2806. PubMed ID: 28734011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
    Malm H; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Weissman M; Wickramaratne P; Artama M; Gingrich JA; Sourander A
    J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):359-66. PubMed ID: 27126849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children.
    El Marroun H; White TJ; van der Knaap NJ; Homberg JR; Fernández G; Schoemaker NK; Jaddoe VW; Hofman A; Verhulst FC; Hudziak JJ; Stricker BH; Tiemeier H
    Br J Psychiatry; 2014 Aug; 205(2):95-102. PubMed ID: 25252317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study.
    Rai D; Lee BK; Dalman C; Golding J; Lewis G; Magnusson C
    BMJ; 2013 Apr; 346():f2059. PubMed ID: 23604083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.